Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)

CAPS Rating: 3 out of 5

A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.

Recs

0
Player Avatar dnblack (38.14) Submitted: 11/17/2010 7:03:40 PM : Outperform Start Price: $12.18 SVNT Score: -100.52

I like TSIF's pitch.

Featured Broker Partners


Advertisement